MLAB Mesa Laboratories Inc

Price (delayed)

$260.19

Market cap

$1.34B

P/E Ratio

394.23

Dividend/share

$0.48

EPS

$0.66

Enterprise value

$1.22B

Highlights
MLAB's equity has surged by 85% year-on-year
Mesa Laboratories's net income has surged by 84% YoY
The company's quick ratio has surged by 124% YoY but it fell by 11% QoQ
The debt has grown by 3.8% YoY

Key stats

What are the main financial stats of MLAB
Market
Shares outstanding
5.14M
Market cap
$1.34B
Enterprise value
$1.22B
Valuations
Price to earnings (P/E)
394.23
Price to book (P/B)
3.29
Price to sales (P/S)
9.66
EV/EBIT
118.08
EV/EBITDA
43.57
EV/Sales
9.1
Earnings
Revenue
$133.94M
EBIT
$10.33M
EBITDA
$27.99M
Free cash flow
$35.08M
Per share
EPS
$0.66
Free cash flow per share
$7.05
Book value per share
$79.16
Revenue per share
$26.92
TBVPS
$66.11
Balance sheet
Total assets
$601.48M
Total liabilities
$195.25M
Debt
$145.68M
Equity
$406.23M
Working capital
$271.17M
Liquidity
Debt to equity
0.36
Current ratio
9.32
Quick ratio
8.83
Net debt/EBITDA
-4.22
Margins
EBITDA margin
20.9%
Gross margin
65%
Net margin
2.4%
Operating margin
9.2%
Efficiency
Return on assets
0.5%
Return on equity
0.8%
Return on invested capital
5.4%
Return on capital employed
1.8%
Return on sales
7.7%
Dividend
Dividend yield
0.18%
DPS
$0.48
Payout ratio
72.7%

MLAB stock price

How has the Mesa Laboratories stock price performed over time
Intraday
-0.5%
1 week
-1.53%
1 month
6.83%
1 year
14.71%
YTD
-9.23%
QTD
6.85%

Financial performance

How have Mesa Laboratories's revenue and profit performed over time
Revenue
$133.94M
Gross profit
$87.01M
Operating income
$12.36M
Net income
$3.27M
Gross margin
65%
Net margin
2.4%
Mesa Laboratories's net income has surged by 84% YoY
The net margin has soared by 60% YoY
MLAB's operating income has soared by 56% YoY
The operating margin has grown by 37% YoY

Growth

What is Mesa Laboratories's growth rate over time

Valuation

What is Mesa Laboratories stock price valuation
P/E
394.23
P/B
3.29
P/S
9.66
EV/EBIT
118.08
EV/EBITDA
43.57
EV/Sales
9.1
The company's EPS has surged by 57% YoY
MLAB's equity has surged by 85% year-on-year
MLAB's price to book (P/B) is 37% less than its 5-year quarterly average of 5.2 but 6% more than its last 4 quarters average of 3.1
The P/S is 31% above the 5-year quarterly average of 7.4
MLAB's revenue is up by 14% year-on-year and by 2.9% since the previous quarter

Efficiency

How efficient is Mesa Laboratories business performance
Mesa Laboratories's return on invested capital has surged by 125% QoQ but it has decreased by 16% YoY
The company's return on sales has surged by 120% QoQ but it fell by 3.8% YoY
MLAB's return on equity is down by 11% year-on-year

Dividends

What is MLAB's dividend history
DPS
$0.48
Dividend yield
0.18%
Payout ratio
72.7%
Recent dividends

Financial health

How did Mesa Laboratories financials performed over time
The company's quick ratio has surged by 124% YoY but it fell by 11% QoQ
MLAB's current ratio has surged by 97% year-on-year but it is down by 12% since the previous quarter
The debt is 64% less than the equity
MLAB's equity has surged by 85% year-on-year
MLAB's debt to equity is down by 44% YoY but it is up by 2.9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.